Greg Wolf to Genes, p53
This is a "connection" page, showing publications Greg Wolf has written about Genes, p53.
Connection Strength
0.505
-
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group. Arch Otolaryngol Head Neck Surg. 2009 Sep; 135(9):869-74.
Score: 0.323
-
Scheel A, Bellile E, McHugh JB, Walline HM, Prince ME, Urba S, Wolf GT, Eisbruch A, Worden F, Carey TE, Bradford C. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer. Laryngoscope. 2016 09; 126(9):E292-9.
Score: 0.130
-
Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003 Aug; 25(8):654-61.
Score: 0.053